Linvoseltamab

9 trials 5 recruiting NNeurology/Psychiatry

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

5 Recruiting

1 Completed trials

4 Sponsors

18 Countries

Phase III

Phase II

Phase I/II

Phase IV

Phase I

Phase I (FiH)

Phase III: 3 Phase II: 2 Phase I/II: 1 Phase IV: 1 Phase I: 1 Phase I (FiH): 1

Indications tested

Waldenstrom´s macroglobulinaemia 1

Sponsors using this IMP

Regeneron Pharmaceuticals Inc. 7 Emn Trial Office S.r.l. Impresa Sociale 1 European Myeloma Network B.V. 1 Region Hovedstaden 1

All trials

9 total

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III 10 countries Regeneron Pharmaceuticals Inc.
A Trial to Study if REGN17372 in Combination with Linvoseltamab is Tolerable for Adult Participants with Relapsed/Refractory Multiple Myelom… Pending

2025-522776-93-00 Phase I 1 country Regeneron Pharmaceuticals Inc.
A multicentre, adaptive, randomised, multidomain, platform trial for dose optimization in the treatment of adult patients with haematologica… Pending

2026-525658-13-00 Phase IV 1 country Region Hovedstaden
A Randomized, Open-Label, Controlled Phase 3 Study Comparing Daratumumab, Lenalidomide and Dexamethasone Induction followed by Linvoseltamab… Recruiting

2024-519827-16-00 Phase III 16 countries Emn Trial Office S.r.l. Impresa Sociale; European Myeloma Network B.V.
A proof-of-concept study to learn whether linvoseltamab can eliminate abnormal plasma cells that may lead to multiple myeloma in adult patie… Recruiting

2023-505242-25-00 Phase II 6 countries Regeneron Pharmaceuticals Inc.
A Window of Opportunity Trial To Learn If Linvoseltamab Is Safe And Well Tolerated, And How Well It Works In adult Participants With Recentl… Recruiting

2022-500800-24-00 Phase II 2 countries Regeneron Pharmaceuticals Inc.
A Trial to Learn if Linvoseltamab is Safe and Works in Adults with Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) Recruiting

2023-507809-34-00 Phase I/II 2 countries Regeneron Pharmaceuticals Inc.
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma Recruiting

2024-511454-45-00 Phase I (FiH) 2 countries Regeneron Pharmaceuticals Inc.
A Study to Learn How Linvoseltamab (REGN5458) Will Work Compared to the Elotuzumab, Pomalidimide and Dexamethasone (EPd) Combination, in Par… Ended

2022-501396-62-00 Phase III 7 countries Regeneron Pharmaceuticals Inc.

Showing 1–9 of 9 trials

← All drugs A–Z